Grant: Applied Research and Development Grants - Level 1
Seneca College of Applied Arts and Technology
$24,998.00
Nano-Particle based thermal barriers for the stabilization of proteinaceous and pharmaceuticalcontainers
EF 2019-20
Résumé
VivaVax is creating new technologies that protect sensitive medicines during transport, and formulations that enhance drug delivery into the body. The World Health Organization estimates that 50% of vaccines are wastedglobally, and up to 70% in developing regions. VivaVax will collaborate with Seneca's School of Biological Science and Applied Chemistry to reduce this number by creating next-generation thermal-barriers for vaccine containers through the development of a novel pore-generation technique within polymer films. Led byProfessor James Mayo and Professor Frank Merante, student Research Assistants (RAs) from Seneca'sBiotechnology Advanced Diploma Program will participate in this project. Improvements developed during thecourse of the project will allow the company to add product lines within its current target market in 2020.Enhancing VivaVax's technology will allow VivaVax to develop two to three new product lines within twoyears of product development.
Programme
Applied Research and Development Grants - Level 1
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
548660-2019
Name nom
Rogers, Ben
Department département
Newham Campus
Organization id
1803
Institution établissement
Seneca College of Applied Arts and Technology
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
24998
Program id
CARD1
Program name en
Applied Research and Development Grants - Level 1
Program name fr
Subventions de recherche et développement appliquée - niveau 1
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1561
Committee name en
Applied Research and Development Grants
Committee name fr
Subventions de recherche et développement appliquée
Area of application code
508
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Polymers, rubber and plastics
Area of application fr
Polymères, caoutchouc et plastiques
Research subject code
2004
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Polymers and coatings
Research subject fr
Polymères et revêtements
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Nano-Particle based thermal barriers for the stabilization of proteinaceous and pharmaceuticalcontainers
Keyword
NSERC
Application summary
VivaVax is creating new technologies that protect sensitive medicines during transport, and formulations that enhance drug delivery into the body. The World Health Organization estimates that 50% of vaccines are wastedglobally, and up to 70% in developing regions. VivaVax will collaborate with Seneca's School of Biological Science and Applied Chemistry to reduce this number by creating next-generation thermal-barriers for vaccine containers through the development of a novel pore-generation technique within polymer films. Led byProfessor James Mayo and Professor Frank Merante, student Research Assistants (RAs) from Seneca'sBiotechnology Advanced Diploma Program will participate in this project. Improvements developed during thecourse of the project will allow the company to add product lines within its current target market in 2020.Enhancing VivaVax's technology will allow VivaVax to develop two to three new product lines within twoyears of product development.
